Publikationen in Zusammenarbeit mit Forschern von Hadassah Medical Center (4)

2021

  1. Final results from the PERUSE study of first-line pertuzumab plus trastuzumab plus a taxane for HER2-positive locally recurrent or metastatic breast cancer, with a multivariable approach to guide prognostication

    Annals of Oncology, Vol. 32, Núm. 10, pp. 1245-1255

  2. Severe toxicity free survival: physician-derived definitions of unacceptable long-term toxicities following acute lymphocytic leukaemia

    The Lancet Haematology, Vol. 8, Núm. 7, pp. e513-e523

2020

  1. Neuroinflammatory Disease as an Isolated Manifestation of Hemophagocytic Lymphohistiocytosis

    Journal of Clinical Immunology, Vol. 40, Núm. 6, pp. 901-916

2014

  1. Performance of current guidelines for diagnosis of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis

    Arthritis and Rheumatology, Vol. 66, Núm. 10, pp. 2871-2880